Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) QNTM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up
Quantum BioPharma Announces Results of Annual General and Special Meeting of Shareholders and Closing of Private Placement of Class A Multiple Voting Shares
Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold
World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
Trading Information
- Previous Close Price
- $1.52
- Day Range
- $1.38–1.64
- 52-Week Range
- $1.33–12.42
- Bid/Ask
- $1.38 / $1.47
- Shares Outstanding
- 8.59M
- Market Cap
- $12.19M
- Volume/Avg
- 78,981 / 154,972
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 7
Valuation
Metric | QNTM |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.11 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | QNTM |
|---|---|
Quick Ratio | 0.57 |
Current Ratio | 1.72 |
Interest Coverage | −46.53 |
Quick Ratio
QNTM
Profitability
Metric | QNTM |
|---|---|
Return on Assets (Normalized) | −76.39% |
Return on Equity (Normalized) | −157.57% |
Return on Invested Capital (Normalized) | −153.74% |
Return on Assets
QNTM
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|>>&!>w | LOCK|>f?Hl | $132B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|Yct>dB | LOCK|Z!$q | $96B | |||
| Moderna Inc MRNA | LOCK|>%!q^X& | LOCK|BP | $81B | |||
| argenx SE ADR ARGX | LOCK|L>NfmTg | LOCK|^?^ | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|?hJL?F | LOCK|yS$ | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|&pR&sHn> | LOCK|%Qgk | $30B | |||
| Incyte Corp INCY | LOCK|?p!q^^ | LOCK|#W% | $24B | |||
| BioNTech SE ADR BNTX | LOCK|<ZK^XG | LOCK|jPN | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|XQJd%? | LOCK|@>%# | $20B | |||
| BridgeBio Pharma Inc BBIO | LOCK|@V!H$> | LOCK|?? | $15B |